
Dendreon Corporation, the troubled manufacturer of high-cost cancer vaccine Provenge, has filed for bankruptcy as a prelude to restructuring its …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

